Additional file 1 of Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues
Emily R. Penick, Nicholas W. Bateman, Christine Rojas, Cuauhtemoc Magana, Kelly Conrads, Ming Zhou, Brian L. Hood, Guisong Wang, Niyati Parikh, Ying Huang, Kathleen M. Darcy, Yovanni Casablanca, Paulette Mhawech-Fauceglia, Thomas P. Conrads & G. Larry Maxwell
Additional file 1: Figure S1. Clinical model to determine surgical algorithm for ovarian cancer patients. A diagnostic surgery is first conducted to determine feasibility of optimal cytoreduction in women found to have ovarian cancer. If patients are determined by the surgeon to have disease burden that is likely to achieve optimally cytoreduction (R0), then patients undergo Primary Debulking Surgery (PDS). If optimal debulking is determined to be unlikely (R1), patients have tissue specimens collected at...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see
our documentation.